Product Introduction:
Vogli Trio combines Glimepiride (0.3 mg), Metformin Hydrochloride (500 mg), and Pioglitazone (80 mg). Glimepiride stimulates insulin secretion, Metformin reduces glucose production by the liver, and Pioglitazone improves insulin sensitivity, working together to maintain optimal glycemic control.
Uses:
-
Management of type 2 diabetes mellitus
-
Control of fasting and postprandial blood sugar levels
-
Used when diet, exercise, and monotherapy are insufficient
Benefits:
-
Provides effective and comprehensive blood glucose control
-
Helps reduce insulin resistance and improve insulin secretion
-
Lowers risk of diabetes-related complications
-
Supports better long-term diabetes management
Composition:
-
Glimepiride 0.3 mg
-
Metformin Hydrochloride 500 mg
-
Pioglitazone 80 mg
Side Effects:
-
Hypoglycemia (low blood sugar)
-
Gastrointestinal upset (nausea, diarrhea)
-
Weight gain (due to Pioglitazone)
-
Edema or fluid retention
-
Rare allergic reactions
Safety Advice:
-
Take with meals to minimize stomach upset
-
Regular monitoring of blood sugar and kidney function advised
-
Inform your doctor if pregnant, breastfeeding, or with heart/liver conditions
-
Avoid alcohol during treatment
-
Do not skip doses or stop without medical advice
